Tatsuya Nishi

Okayama, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications

ULK1, a novel therapeutic target to delay drug tolerance to EGFR-TKIs in an EGFR-mutant non-small cell lung cancer model.

ULK1, a novel therapeutic target to delay drug tolerance to EGFR-TKIs in an EGFR-mutant non-small cell lung cancer model.

Journal: Lung cancer (Amsterdam, Netherlands)
Published: November 16, 2025

Incidence of B-cell Malignancies in Patients with Lung Cancer Receiving PD-1 Blockade Therapy.

Incidence of B-cell Malignancies in Patients with Lung Cancer Receiving PD-1 Blockade Therapy.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: September 11, 2025

Author Correction: Immune evasion through mitochondrial transfer in the tumour microenvironment.

Author Correction: Immune evasion through mitochondrial transfer in the tumour microenvironment.

Journal: Nature
Published: July 27, 2025

A Case Report on the Development of Ulcerative Colitis During Osimertinib Therapy for Epidermal Growth Factor Receptor Mutation-Positive Non-Small-Cell Lung Cancer.

A Case Report on the Development of Ulcerative Colitis During Osimertinib Therapy for Epidermal Growth Factor Receptor Mutation-Positive Non-Small-Cell Lung Cancer.

Journal: Respirology case reports
Published: May 26, 2025

Publisher Correction: Immune evasion through mitochondrial transfer in the tumour microenvironment.

Publisher Correction: Immune evasion through mitochondrial transfer in the tumour microenvironment.

Journal: Nature
Published: February 13, 2025

Efficacy of amivantamab, a bi-specific antibody targeting EGFR and MET, in ALK-rearranged non-small-cell lung cancer cell lines.

Efficacy of amivantamab, a bi-specific antibody targeting EGFR and MET, in ALK-rearranged non-small-cell lung cancer cell lines.

Journal: Lung cancer (Amsterdam, Netherlands)
Published: November 22, 2024

TXB-001, A Newly-Developed Polymer-Conjugated Anthracycline, Alleviates Anthracycline-Induced Cardiotoxicity.

TXB-001, A Newly-Developed Polymer-Conjugated Anthracycline, Alleviates Anthracycline-Induced Cardiotoxicity.

Journal: Cardiovascular toxicology
Published: October 18, 2024

PI3K/Akt Signaling Pathway Regulates CD155 Expression Involved in Resistance to Cancer Immunotherapy.

PI3K/Akt Signaling Pathway Regulates CD155 Expression Involved in Resistance to Cancer Immunotherapy.

Journal: Cancer immunology research
Published: September 04, 2024

Cone-Beam Computed Tomography-Guided Marking of Small Pulmonary Nodules with Surgical Clips.

Cone-Beam Computed Tomography-Guided Marking of Small Pulmonary Nodules with Surgical Clips.

Journal: The Kurume medical journal
Published: June 14, 2023

Efficacy of gilteritinib in comparison with alectinib for the treatment of ALK-rearranged non-small cell lung cancer.

Efficacy of gilteritinib in comparison with alectinib for the treatment of ALK-rearranged non-small cell lung cancer.

Journal: Cancer science
Published: April 07, 2023

CDK4/6 signaling attenuates the effect of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in EGFR-mutant non-small cell lung cancer.

CDK4/6 signaling attenuates the effect of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in EGFR-mutant non-small cell lung cancer.

Journal: Translational lung cancer research
Published: February 11, 2023

Immune evasion through mitochondrial transfer in the tumour microenvironment.

Immune evasion through mitochondrial transfer in the tumour microenvironment.

Journal: Nature
Published: January 05, 2023
Showing 1-12 of 27

Last Updated: 09/26/2026